Nivolumab (Opdivo) for Metastatic Melanoma and Metastatic NSCLC

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2015年 / 57卷 / 1470期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：85 / 87
页数：3
相关论文
共 50 条
  • [1] Nivolumab (Opdivo) plus Ipilimumab (Yervoy) for Metastatic Melanoma
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1483): : 168 - 168
  • [2] Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
    Mansouri, Alireza
    Moraes, Fabio Y.
    Zadeh, Gelareh
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22): : 2177 - 2178
  • [3] The safety of nivolumab for the treatment of metastatic melanoma
    O'Reilly, Aine
    Larkin, James
    [J]. EXPERT OPINION ON DRUG SAFETY, 2017, 16 (08) : 955 - 961
  • [4] Nivolumab success in untreated metastatic melanoma
    Wilkinson, Emma
    [J]. LANCET ONCOLOGY, 2015, 16 (01): : E9 - E9
  • [5] Nivolumab exposure in a hemodialysis patient with metastatic melanoma
    Gulikers, Judith L.
    Croes, Sander
    Schreurs, Marco J. W.
    Litjens, Elisabeth J. R.
    Aarts, Maureen J. B.
    van Geel, Robin M. J. M.
    [J]. MELANOMA RESEARCH, 2021, 31 (06) : 579 - 581
  • [6] Myosteatosis is prognostic in metastatic melanoma treated with nivolumab
    Youn, Susie
    Reif, Rebecca
    Chu, Michael P.
    Smylie, Michael
    Walker, John
    Eurich, Dean T.
    Ghosh, Sunita
    Sawyer, Michael B.
    [J]. CLINICAL NUTRITION ESPEN, 2021, 42 : 348 - 353
  • [7] Nivolumab + relatlimab for the treatment of unresectable or metastatic melanoma
    Kosela-Paterczyk, Hanna
    Rutkowski, Piotr
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (09) : 993 - 993
  • [8] The efficacy of nivolumab for unresectable metastatic mucosal melanoma
    Takahashi, A.
    Tsutsumida, A.
    Namikawa, K.
    Nakamura, Y.
    Muto, I.
    Yamazaki, N.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [9] Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
    Tawbi, Hussein A.
    Forsyth, Peter A.
    Algazi, Alain
    Hamid, Omid
    Hodi, F. Stephen
    Moschos, Stergios J.
    Khushalani, Nikhil I.
    Lewis, Karl
    Lao, Christopher D.
    Postow, Michael A.
    Atkins, Michael B.
    Ernstoff, Marc S.
    Reardon, David A.
    Puzanov, Igor
    Kudchadkar, Ragini R.
    Thomas, Reena P.
    Tarhini, Ahmad
    Pavlick, Anna C.
    Jiang, Joel
    Avila, Alexandre
    Demelo, Sheena
    Margolin, Kim
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (08): : 722 - 730
  • [10] Checkpoint immunotherapy by nivolumab for treatment of metastatic melanoma
    Koppolu, Veerendra
    Vasigala, Veneela Krishna Rekha
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 (06) : 1167 - 1175
12345